News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer
Kohei Shitara/X
Feb 1, 2025, 07:13

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared an article on X he and his colleagues authored:

“Pleased to share P2 results of futibatinib for FGFR2-amplified gastric cancer: ORR 17.9%. Shows some activity but underscores need for better options. Eagerly awaiting P3 chemo + bemarituzumab data.”

Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications

Authors: Taroh Satoh et al.

Kohei Shitara: P2 results of futibatinib for FGFR2-amplified gastric cancer

cancer Hidekazu Hirano Jaffer Ajani Jill Kremer Joon Oh Park Kazunori Honda Keun-Wook Lee Kohei shitara Lucia Nogova Mark Mina Mei Liu Min-Hee Ryu Nanae Hangai OncoDaily Oncology Philippe Barthélémy Sun Young Rha Taroh Satoh Toshihiko Doi
Special Coverage
Blog
Apr 23, 2025, 10:17
Join IARC’s new webinar series on Research for Implementation in Cancer Prevention
Drugs
Apr 23, 2025, 10:15
Binimetinib (Mektovi): What patients need to know?
Blog
Apr 23, 2025, 10:12
Matthew Kurian: From ASCENT-04 may reshape frontline therapy for mTNBC
Blog
Apr 23, 2025, 10:07
Paolo Tarantino: ADCs are rapidly moving to earlier line treatment for breast cancer
Blog
Apr 23, 2025, 10:05
Tools to help gauge your personal breast cancer risk - Susan G. Komen
Blog
Apr 23, 2025, 08:55
Ahmed Alanazi: ADCs are now reshaping the standard of care for metastatic Breast Cancer
Blog
Apr 23, 2025, 08:43
Milagros Rosado Elia: Darcy Burbage as the recipient of the National Oncology Nursing Society's "Excellence in Social Media Impact Award" for 2025
Science
Apr 23, 2025, 08:35
Rachit Khandelwal: India’s First POC CAR-T Trial shows 100% CR in B-ALL
Blog
Apr 23, 2025, 08:26
The importance of trusting our instincts and advocating for our health - Digestive Cancers Europe
Blog
Apr 23, 2025, 08:18
FDA is taking bold steps to restore public trust - U.S. FDA
Blog
Apr 23, 2025, 08:09
Shrenik Shah Shares Journey from Cancer Survivor to Global Communicator
Blog
Apr 23, 2025, 07:49
Change Our Future Supports AACR 2025 Program for High School Students